Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · International Stock · BNY Mellon / Dreyfus

DRRAX Expense Ratio & Fees

Ticker DRRAX · · Holdings as of Jul 31, 2026

Expense ratio
1.19%$119/yr per $10k
5-yr return
+2.6%annualized
1-yr return
+5.8%as of Dec 2025
Net assets
$844.7Mall share classes
Holdings
176

Bottom line

What is DRRAX's expense ratio?

DRRAX's expense ratio is 1.19%, or about $119 a year on every $10,000 invested. That is more expensive than 75% of international stock funds we track (median 0.9%). This share class also charges a front-end sales load of up to 5.75%, taken from your investment when you buy.

Updated Feb 26, 2026

DRRAX fee table

Net expense ratio1.19%
Gross expense ratio1.24%
Management fee0.75%
12b-1 (distribution) fee0%
Other expenses0.45%
Acquired fund fees0.04%
Fee waiver / reimbursement-0.05%
Max front-end sales load5.75%
Max deferred sales charge0%

Source: Fund prospectus fee table, filed Feb 26, 2026

What DRRAX costs in dollars

The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:

1 year3 years5 years10 years
DRRAX$689$941$1,212$1,985

Source: Fund prospectus expense example

The long-run cost of fees

On $100,000 growing at 6% a year for 20 years, a 1.19% expense ratio costs roughly $64,800 in lost growth, versus about $50,300 for the median international stock fund (0.9%).

Cheapest way to own BNY Mellon Global Real Return Fund

All share classes
TickerClassExpense ratioFront load
DRRYXClass Y0.87%0%
DRRIXClass I0.94%0%
DRRAXClass A1.19%5.75%
DRRCXClass C1.94%0%